InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024
InfuSystem a New Buy at B Riley on Infusion Pump Business
InfuSystems Holdings Analyst Ratings
B.Riley Financial Initiates InfuSystems(INFU.US) With Buy Rating, Announces Target Price $13
Craig-Hallum Maintains InfuSystems(INFU.US) With Buy Rating
Craig-Hallum analyst Matt Hewitt maintains $InfuSystems(INFU.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 42.1% and a total average return of -4.2% over the
Craig-Hallum Maintains InfuSystems(INFU.US) With Buy Rating, Cuts Target Price to $8
Craig-Hallum analyst Matt Hewitt maintains $InfuSystems(INFU.US)$ with a buy rating, and adjusts the target price from $15 to $8.According to TipRanks data, the analyst has a success rate of 42.2%
Sanara MedTech, InfuSystem Joint Venture to Distribute ChemoMouthpiece Kits
Express News | Sanara Medtech Inc - Si Technologies to Distribute Chemomouthpiece’s Kits to 3,000 Cancer Centers
Express News | Sanara Medtech Inc - Draws $15.5 Million on Term Loan With Crg Servicing
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement With, and Minority Investment In, ChemoMouthpiece, LLC
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement With ChemoMouthpiece, LLC
Express News | Sanara Medtech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement With, and Minority Investment in, Chemomouthpiece, LLC
Express News | InfuSystem and Sanara Medtech Inc. Announce Exclusive United States Distribution Agreement With Chemomouthpiece, LLC
InfuSystem to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024
NYSE American Net Change Percentage Gainers & Losers
Earnings Call Summary | InfuSystems(INFU.US) Q2 2024 Earnings Conference
InfuSystem Holdings, Inc. (INFU) Q2 2024 Earnings Call Transcript
InfuSystems | 10-Q: Q2 2024 Earnings Report
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Posts Q2 Revenue $33.7M, Vs. Street Est of $33.2M
InfuSystems Sees 2024 Net Rev Growth in High-Single-Digit Range >INFU